The pattern of inheritance of autoantibodies in eight families chosen from a pool of 110 families of patients with systemic lupus erythematosus (SLE) is described. In all the eight families at least two members were already affected by SLE. In total, 19 patients and 43 first degree relatives were examined.
In almost all known autoimmune diseases there is a tendency for these conditions to run in families. This may occur as a greater incidence of a given disorder in relatives of patients than in a control group, 1- or as an increased incidence of other autoimmune diseases in family members of patients with specific disorders.5 6 The appearance of systemic lupus erythematosus (SLE) in identical twins was reported in 1951 by Davis and Gutridge,7 and five years later Glagov and Gechman diagnosed SLE in both a mother and her daughter. 8 In 1964 Leonhardt published the results of a larger study which compared 113 patients with SLE and about 500 of their relatives with a group of 324 subjects consisting of patients' spouses and their relatives.9 When summarising his study, Leonhardt again suggested the existence of a genetic tendency towards this autoimmune disease.
Winchester and Nufiez-Roldan studied 33 families with two or more cases of lupus and found a parent offspring concordance in 15.10 They estimated that the susceptibility to lupus is determined by at least four independently segregating genes, some of which seem to have a dominant mode of inheritance.
Not only do autoimmune diseases themselves develop with an increased incidence among family members but laboratory findings related to these diseases are also found with an increased incidence in asymptomatic relatives of patients known to have autoimmune disorders. As already mentioned, Leonhardt described hypergammaglobulinaemia in asymptomatic siblings of patients with SLE,' and linked this finding to the hereditary state related to the development of the disease itself. Holman and Deicher reported hypergammaglobulinaemia in 11 of 57 relatives of patients with SLE belonging to 18 families, and a borderline (upper limit of normal) level in an additional 10 relatives." Furthermore Antinuclear antibodies (Sm, RNP, SSA, SSB) were detected using autoantigens extracted from fresh thymus cells.'8 The plates were coated with 5 ,tg/ml of the antigen and the procedure was carried out as described above.
Antinuclear antibodies and antibodies to dinitrophenyl, extractable nuclear antigens, tRNA, and mitochondria were also screened for, as described in detail previously. ' Figure 3 (family 3) depicts an additional family in which the parents seemed to be completely healthy, yet four sisters (II.4-II.7) developed overt SLE; one (II.7) died before we studied her. It might be that the haplotype inherited from the father conferred suceptibility to SLE. The father with this haplotype was weakly positive for antibodies to dsDNA, SSA, and SSB (data not shown). We cannot discount the possible influence of the haplotype inherited from the mother as she was not screened for autoantibodies. Figure 4 (family 4) represents another family with multiple cases of SLE with three affected sisters (11.1-11.3) having different HLA phenotypes, again with diverse patterns of autoantibodies. In this family the mother had many antinuclear autoantibodies and all the children tested, including four sons, had autoantibodies. Figure 5 (family 5) shows another complex family with two parents having antinuclear autoantibodies. Two daughters (11.3, 11.13) Figure 8 (family 8) depicts another family with multiple cases of SLE, in which all the healthy relatives tested have developed a wide variety of autoantibodies.
Although in these families there were some members with null alleles of C4A or C4B, no cosegregation was found between the presence of any antibody and either of these null alleles in this group of families. The table summarises the incidence of autoantibodies found among the patients with SLE and their healthy relatives.
Discussion
The aim of the study was to analyse the pattern of inheritance of a panel of autoantibodies in families with multiple cases of SLE and their first degree relatives. The inheritance seemed to be related to some unknown genetic factors but not clearly related to HLA in those 'multiple case' families where the genetic predisposition often came from both parents as judged by the phenotypes shared or the presence of autoantibodies in them. The existence of even a great variety of antinuclear autoantibodies in the serum of a subject was not necessarily associated with overt disease. Only prolonged follow up will point to the pathogenicity of the autoantibodies in first degree relatives of patients with SLE.
Surprisingly, the incidence of the 16/6 idiotype among patients and their relatives was low. The 16/6 idiotype was reported by us to be a pathogenic idiotype.27 3>32 Its titres correlated with disease activity and it was found to be deposited in tissue afflicted by SLE. Recently, immunisation of naive mice with the 16/6 idiotype has been followed by induction of an SLE-like disease.29 31 3 Therefore, we expected increased titres of the 16/6 idiotype to be found in higher numbers in patients and first degree relatives in families with multiple cases of SLE in comparison with the incidences reported previously (40% and 25% respectively). 32 Conceivably, in the families reported here other pathogenic idiotypes might play a significant part. We have reported previously a pathogenetic role for the 16/6 idiotype in at least one family, but the members of that family had an additional risk factor for SLE-namely, C4 complement component deficiencies either at C4A or C4B. 34 It would be interesting to see whether the autoantibody burden is higher in families with multiple cases of SLE than in families with only single case, particularly as our data suggest that 'multiple case' families may be genetically different from single case ones. On the other hand, the presence of this idiotype in healthy relatives supports the suggestion that it is a germline encoded natural autoantibody. The presence or absence of this phenotype in healthy relatives reflects B cell activation (for example, by Epstein-Barr virus) or the presence of antibodies to the idiotype which impair its detec- tion. This might also occur in patients with SLE at the time of disease remission-hence the correlation of the 16/6 idiotype with disease activity.
